Search results
Results from the WOW.Com Content Network
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Tuesday, Emergent BioSolutions Inc. (NYSE: ... This new procurement funding is from Emergent’s existing 10-year contract with the Biomedical Advanced Research and Development Authority.
(Reuters) - Drugmaker Emergent BioSolutions said on Monday that it would reduce its workforce in Lansing, Michigan, by up to 70 roles as part of its ongoing restructuring efforts.
US FDA approves Emergent BioSolutions' anthrax vaccine July 20, 2023 at 3:19 PM (Reuters) -Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax ...
After the February 2014 acquisition of Cangene Corporation by Emergent BioSolutions, Emergent took control of Cangene's products and contracts, including BAT. [12] In March 2017, Emergent extended its contract with the Biomedical Advanced Research and Development Authority (BARDA), adding $53 million in value throughout 2022 for the production ...
ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur in 2008, before selling the smallpox vaccine to Emergent Biosolutions in 2017. Six strains of vaccinia were isolated from 3,000 doses of Dryvax and found to exhibit significant variation in virulence.
Alibek was president, chief scientific officer, and chief executive officer at AFG Biosolutions, Inc in Gaithersburg, Maryland, [15] where he and his scientific team continued their development of advanced solutions for antimicrobial immunity
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.